Patient Leaflet Updated 07-May-2026 | Unicorn Pharmaceuticals Limited
Noradrenaline 0.16 mg/ml solution for infusion
Noradrenaline 0.16 mg/ml solution for infusion
Noradrenaline (as noradrenaline tartrate)
The full name of the your medicine is Noradrenaline 0.16 mg/ml solution for infusion. It is referred to as Noradrenaline infusion throughout this leaflet.
1. What Noradrenaline infusion is and what it is used for
2. What you need to know before Noradrenaline infusion is given to you
3. How to use Noradrenaline infusion
4. Possible side effects
5. How to store Noradrenaline infusion
6. Contents of the pack and other information
Noradrenaline infusion is a medicine that belongs to the group of adrenergic and dopaminergic agents.
Noradrenaline infusion is indicated in adults weighing over 50 kg for the on-going treatment of hypotensive emergencies with escalating noradrenaline dose requirements.
The product is for adults only.
Talk to your doctor, pharmacist or nurse before using Noradrenaline infusion
During the infusion of noradrenaline, your doctor will check continuously your blood pressure and cardiac frequency (heart rate).
Noradrenaline 0.16 mg/ml solution for infusion is indicated for adults only.
Tell your doctor, pharmacist or nurse if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
A number of medicines are known to increase the toxic effects of noradrenaline, such as:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking any medicine.
Noradrenaline may harm the unborn baby. Your doctor will decide if you should be given noradrenaline infusion.
None stated.
This medicine contains 165.3 mg sodium (main component of cooking/table salt) in each 50 ml vial. This is equivalent to 8.3% of the recommended maximum daily dietary intake of sodium for an adult.
Noradrenaline infusion will be used to you in hospital by a doctor or nurse. The dose of noradrenaline solution for infusion will depend on your condition. Your doctor will know the best dose to use.
It is unlikely that you will receive too much as this medicine will be given to you in hospital.
However, talk to your doctor or nurse if you have any concerns.
Symptoms of overdose are severe high blood pressure, slow heartbeat, violent headache, light sensitivity, pain in the chest, pale colour, intense sweating and vomiting.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The frequency of the adverse reactions cannot be estimated from the available data.
Tell your doctor as soon as possible if you experience:
In case of hypersensitivity or overdose, the following effects may appear more frequently: hypertension (high blood pressure), photophobia (abnormal intolerance to visual perception of light), retrosternal pain (thoracic pain), pharyngeal pain (throat pain), pallor, intense sweating and vomiting.
Your doctor will monitor your blood pressure and blood volume.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date {month/year} which is stated on the outer carton and on the vial.
The expiry date refers to the last day of that month.
After the first opening, the product should be used immediately.
Do not store above 25°C. Do not refrigerate or freeze. Store in the original package in order to protect from light.
Do not throw away any medicines via wastewater. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is noradrenaline (as noradrenaline tartrate)
Each ml of solution for infusion contains 0.32 mg noradrenaline tartrate equivalent to 0.16 mg noradrenaline base. Each 50 ml vial contains 16 mg of noradrenaline tartrate equivalent to 8 mg of noradrenaline base.
The other ingredients are Sodium Chloride, Hydrochloric acid 1 N (for pH-adjustment), Water for injections.
This medicinal product is presented as solution for infusion. The solution is clear colourless solution.
The medicinal product is available in packs containing 1 vial of solution for infusion.
This leaflet was last revised in April 2026
Devonshire House, 582 Honeypot Lane, Stanmore, HA7 1JS
+44 20 3846 6761
02087325447
02087325447
www.unicornpharma.co.uk